Partner, KPMG’s healthcare and life sciences deal advisory practice
We’ll continue to see consolidation in the form of roll-ups— physician practices, specialty groups. There will be moderate investment and fairly high valuations in home health, primary-care physicians, specialty physicians and retailcentric medical groups. Other areas where we expect to see significant amounts of investment activity and significant valuations are healthcare IT and care management solutions. What’s driving that is not necessarily innovation, but this need for scale. We’re still going to see a ton of consolidation in some of these areas over the next five to 10 years, because it’s a necessary requirement as we continue on this journey.
—AS TOLD TO TARA BANNOW